Ovarian Age vs Ovarian Reserve vs Egg Quality — What Each One Actually Means

What exactly is ovarian reserve?

Ovarian reserve means the number of oocytes, or eggs, remaining in the ovaries.

A woman is born with a finite supply of oocytes. That pool declines throughout life through a normal process called atresia, in which follicles are lost whether or not they ever reach ovulation.

We cannot open the ovary and count the microscopic reserve. Instead, we estimate it using markers that correlate with the pool of small follicles.

Two of the most useful are:

• AMH — anti-Müllerian hormone. AMH is produced mainly by the granulosa cells surrounding small developing follicles. Because those follicles represent part of the recruitable pool, AMH gives us an indirect estimate of ovarian reserve.
• AFC — antral follicle count. Antral follicle count is measured by transvaginal ultrasound. The clinician counts the small antral follicles visible in both ovaries, typically in the early follicular phase.

The American Society for Reproductive Medicine describes AMH and AFC as the most sensitive and reliable markers of ovarian reserve. But the same guidance makes the limitation equally clear: they are good predictors of oocyte yield and ovarian response, and poor independent predictors of overall reproductive potential. See the ASRM committee opinion on testing and interpreting measures of ovarian reserve.

That distinction is everything.

At EC Clinic in Dublin, ovarian-reserve markers are interpreted inside a reproductive health consultation, not handed over as a stand-alone fertility score.

If AMH is not a fertility score, what is it actually good for?

AMH is particularly useful when we need to plan controlled ovarian stimulation.

For example, in IVF, the clinical team wants to estimate whether the ovaries are likely to respond with relatively few follicles, an average response or an excessive response. That affects counselling, medication dosing, safety and expectations around how many eggs might be retrieved.

This is the context in which AMH is strongest.

It is much less useful for saying, “Will I conceive naturally this month?” In women with unproven fertility, ovarian-reserve markers have been poor predictors of fecundability — the chance of conceiving in a menstrual cycle — and cumulative pregnancy.

So if someone offers an AMH blood test as a stand-alone “fertility test,” I would want you to ask what, exactly, they plan to conclude from it.

What does egg quality mean medically?

“Egg quality” is not a formal laboratory number. It is shorthand for the biological competence of an oocyte.

For an egg to contribute to a healthy embryo, several things need to happen correctly:

• it must mature properly
• its chromosomes must separate accurately
• it must be capable of fertilisation
• it must support the first stages of embryo development

One key process is meiosis, the special type of cell division that reduces the egg’s chromosome number before fertilisation. During this process, a microscopic structure called the meiotic spindle helps organise and separate chromosomes.

If chromosomes do not separate correctly, the egg or embryo can end up with an abnormal chromosome number. This is called aneuploidy.

Mitochondria — the energy-producing structures inside cells — also matter because oocyte maturation and early embryo development require enormous amounts of energy. DNA integrity, oxidative stress, the follicular environment and many other cellular processes also contribute.

This is why there is no honest one-number “egg quality test.” The biology is more complicated than that.

Why does age matter so much if AMH can be the same in two women?

Because quantity and chromosomal competence are different variables.

A younger woman can have a relatively low ovarian reserve but still have a higher proportion of chromosomally competent eggs for her age. An older woman can have a relatively reassuring AMH but still face the age-related increase in aneuploidy.

Age is therefore a much stronger predictor of reproductive success than ovarian-reserve testing alone.

This does not mean every woman’s fertility suddenly falls off a cliff on one birthday. Population data describe a curve, not a deadline. But the biology of age is real and cannot be cancelled by a good AMH result.

Does low AMH mean I cannot conceive naturally?

No.

A low AMH generally suggests a smaller pool of recruitable follicles. In IVF it may predict a lower egg yield from stimulation. But it does not prove that the egg released in a natural cycle cannot be fertilised.

ASRM specifically cautions that ovarian-reserve testing should not be used as a fertility test in women with unproven fertility, and extremely low AMH should not be used by itself to refuse IVF treatment.

This is one of the most important places where context changes the emotional meaning of a result.

Low AMH can be significant. It may affect timing, counselling and treatment planning. But “significant” is not the same as “hopeless.”

Does high AMH mean I have plenty of time?

No.

High AMH usually reflects a larger cohort of small follicles. It is also common in polycystic ovary syndrome, where many small follicles can be visible.

In fertility treatment, a high AMH may predict a strong ovarian response. That can be useful, but it can also mean the stimulation plan needs to be designed carefully to reduce the risk of excessive response.

It does not tell us that egg quality is high. It does not cancel age. And it does not guarantee natural conception.

What about FSH? Why does everyone talk about AMH now?

FSH, or follicle-stimulating hormone, can also provide information about ovarian function, particularly when measured in the early follicular phase. But FSH tends to rise later in the decline of ovarian reserve and can vary more between cycles.

AMH is often more convenient because it is relatively stable across much of the cycle, although hormonal contraception can lower AMH values and should be considered when interpreting a result.

That does not make AMH “better fertility.” It makes it a useful biomarker for a specific purpose.

Can an ultrasound tell egg quality?

No, but it adds very useful context.

A fertility scan can assess:

• antral follicle count
• ovarian appearance
• cysts or endometriomas
• uterine fibroids or structural findings
• endometrial appearance

In other words, the scan can answer anatomical and reserve-related questions that AMH cannot.

A strong fertility assessment combines history, age, cycle pattern, symptoms, ovarian-reserve markers when appropriate, ultrasound findings and — when a couple is trying to conceive — partner or semen factors as relevant.

Fertility is never just an ovary in isolation.

Is it true that an egg takes 90 days to mature?

This is where social-media fertility language needs a correction.

Follicles pass through a long developmental process that begins many months before ovulation. The final months do involve active follicular growth and changes in the environment surrounding the oocyte. That is probably where the “90 days” narrative came from.

But “your egg takes 90 days, therefore you can transform egg quality in 90 days” is not a scientifically valid conclusion.

There is no proven 90-day programme that reverses reproductive ageing or age-related aneuploidy.

There is also no supplement that has been shown to turn an older egg into a younger one.

That does not make lifestyle irrelevant. It means we need to be precise about what lifestyle can and cannot do.

What can I genuinely influence before trying to conceive or starting fertility treatment?

There are meaningful things you can do because reproductive health happens inside a whole body.

• Do not smoke. Smoking is associated with poorer reproductive outcomes and earlier ovarian ageing. If you smoke, stopping is one of the highest-value changes you can make.
• Eat adequately, not perfectly. Fertility does not require a detox. Severe calorie restriction, nutritional deficiency and disordered eating can disrupt reproductive function. Correct genuine deficiencies rather than taking a suitcase of supplements “just in case.”
• Look after metabolic health. Poorly controlled diabetes, significant insulin resistance and other metabolic conditions can affect pregnancy and reproductive health. Treat the condition, not a social-media “hormone reset.”
• Review medications and supplements. Some medications genuinely matter when trying to conceive. Others have no fertility relevance. Bring the whole list, including supplements, to a clinician so decisions are based on interaction and evidence rather than fear.
• Manage diagnosed conditions. Endometriosis, thyroid disease, PCOS and other conditions need individual management. The goal is not to blame them for every fertility question, but to include known conditions in the plan.
• Use time intelligently. For many women, the most powerful modifiable factor is not a supplement. It is when they seek advice. If you know you want children but not yet, a fertility conversation can help you understand options. If you have been trying without success, age and duration of trying help decide when further assessment is appropriate.

When does ovarian-reserve testing actually help?

It helps when there is a defined question, for example:

• planning IVF or ovarian stimulation
• counselling about expected ovarian response
• investigating fertility in the context of age and history
• discussing fertility preservation
• establishing context before certain treatments that may affect ovarian function

It is much less useful as a casual “fertility MOT” where the patient is given a single number and sent away.

At EC Clinic, fertility and reproductive health assessment is positioned as assessment and interpretation, not a promise of outcome. Ultrasound and monitoring can provide information; they cannot guarantee pregnancy.

Medically reviewed by Dr. Eliana Castañeda, Obstetrician-Gynaecologist and Aesthetic Specialist · 7 September 2026

— Dr. Eliana Castañeda
Obstetrician-Gynaecologist and Aesthetic Specialist · Medical Director, EC Clinic Dublin